Advanced search
Publication Cover
Vascular Health and Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
77
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Harold E Bays1 Louisville Metabolic & Atherosclerosis Research Center (L-MARC), Louisville, KY, USA
,
Eliot A Brinton2 Utah Foundation for Biomedical Research, Salt Lake City, UT, USA
,
Joseph Triscari3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Erluo Chen3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Darbie Maccubbin3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Alexandra A MacLean3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Kendra L Gibson3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Rae Ann Ruck3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Amy O Johnson-Levonas3 Merck & Co, Inc., Whitehouse Station, NJ, USA
,
Edward A O’Neill3 Merck & Co, Inc., Whitehouse Station, NJ, USA
&
Yale B Mitchel3 Merck & Co, Inc., Whitehouse Station, NJ, USACorrespondence[email protected]
 show all
Pages 165-172 | Published online: 24 Feb 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.